Search - tctmd.com

Displaying 1 - 20 of 20

Sort: Relevancy | Date

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

News Daily News

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Michael O'Riordan

October 03, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Daily News

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Michael O'Riordan

April 25, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

News Daily News

糖尿病对 DES 治疗的患者的影响甚于病变复杂性

L.A. McKeown

February 03, 2016

News Daily News

La Diabetes Influye Más que la Complejidad de la Enfermedad en Pacientes Tratados con SLF

L.A. McKeown

February 03, 2016

News Daily News

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

L.A. McKeown

February 03, 2016

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Industry News

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

October 14, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

U.S. to vie with India for top bioabsorbable stent market after FDA approval

June 25, 2015

News Industry News

India Coronary Stent Market to be Tripled by 2021

May 05, 2015

News Daily News

Un Registro Japonés Analiza los Índices de ACV para CABG con Bomba, sin Bomba y PCI

L.A. McKeown

October 09, 2012

News Daily News

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

L.A. McKeown

October 09, 2012

News Conference News EuroPCR 2012

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Jason Kahn

May 15, 2012

Presentation TCTAP 2012

Indian TUXEDO Trial In Medically Treated Diabetics

Presenter: Upendra Kaul

April 26, 2012

News Daily News

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

July 15, 2011

Advertisement

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

Ipsilateral Ulnar Compression Significantly Reduces Risk of Radial Artery Occlusion After Transradial PCI

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

糖尿病患者（即使需要胰岛素）中依维莫司支架优于紫杉醇支架：TUXEDO 分析

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

糖尿病对 DES 治疗的患者的影响甚于病变复杂性

La Diabetes Influye Más que la Complejidad de la Enfermedad en Pacientes Tratados con SLF

Diabetes More Influential Than CAD Complexity in DES-Treated Patients

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

U.S. to vie with India for top bioabsorbable stent market after FDA approval

India Coronary Stent Market to be Tripled by 2021

Un Registro Japonés Analiza los Índices de ACV para CABG con Bomba, sin Bomba y PCI

Japanese Registry Assesses Stroke Rates for Off- vs. On-pump CABG, PCI

Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations

Indian TUXEDO Trial In Medically Treated Diabetics

PCI Feasible Even in CAD Patients with End-Stage Liver Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content